MIR-138-5P inhibits the progression of prostate cancer by targeting FOXC1

Mol Genet Genomic Med. 2020 Apr;8(4):e1193. doi: 10.1002/mgg3.1193. Epub 2020 Feb 28.

Abstract

Background: Studies have suggested that micro-RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR-138-5P (613394) in prostate cancer (PCa) remains unclear.

Methods: Expression level of MIR-138-5P in PCa cell lines and normal cell line was analyzed with the quantitative real-time PCR method. Cell counting kit-8 assay, colony formation assay, wound-healing assay, and transwell invasion assay were performed to analyze the biological functions of MIR-138-5P.

Results: We showed MIR-138-5P expression level was significantly decreased in PCa cell lines compared with the normal cell line. Overexpression of MIR-138-5P inhibits PCa cell proliferation, colony formation, cell migration, and cell invasion in vitro. Mechanistically, we showed Forkhead box C1 (FOXC1, 601090) was a direct target for MIR-138-5P in PCa. We confirmed that overexpression of FOXC1 partially reversed the effects of MIR-138-5P on PCa cell behaviors.

Conclusions: Collectively, we showed that MIR-138-5P functions as a tumor suppressor gene in PCa via targeting FOXC1.

Keywords: FOXC1; MIR-138-5P; prostate cancer; tumor suppressor gene.

MeSH terms

  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Forkhead Transcription Factors / genetics*
  • Forkhead Transcription Factors / metabolism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / metabolism
  • Up-Regulation

Substances

  • FOXC1 protein, human
  • Forkhead Transcription Factors
  • MIRN138 microRNA, human
  • MicroRNAs